Global markets are sending mixed signals right now. Housing data, consumer credit trends and inflation readings are pulling rates and risk sentiment in different directions. For investors, that can feel messy, but it also creates room for companies with solid balance sheets and clear earnings growth potential to stand out. The Healthy high growth potential screener focuses on exactly that combination. It looks for stocks where analysts expect strong earnings growth over the next 3 years and where the financial foundations are considered acceptable. In this article, you will see 3 of the strongest candidates from that screener.

Genius Sports (GENI)

Overview: Genius Sports provides the data and technology that sit behind live sports, helping leagues, betting operators and media partners collect in-game statistics, stream matches, run integrity monitoring and serve targeted digital advertising to fans.

Operations: Genius Sports reports all of its US$713.45m in revenue from data processing services across markets including the United States, Gibraltar, other parts of Europe, the Americas and the rest of the world.

Market Cap: US$1.95b

Genius Sports is interesting if you want exposure to the growth of regulated sports betting and richer in-game fan experiences. The company holds exclusive data rights with major leagues, sells live data and streaming to sportsbooks, and is building higher margin products such as BetVision and AI powered advertising tools for brands. Analysts see strong earnings growth, but you are still looking at a business that reported a loss of US$55.47m in Q1 2026 and has taken on sizeable term loan and revolving debt facilities. That mix of high growth expectations, ongoing losses and more leverage creates both room for upside and meaningful risk that deserves a closer look.

Genius Sports sits at the crossroads of live data, betting and AI advertising, yet the real story is how that growth pitch stacks up against fresh losses and new debt. Get the 2 key rewards and 1 important warning sign

Kiniksa Pharmaceuticals International (KNSA)

Overview: Kiniksa Pharmaceuticals International is a biopharmaceutical company that develops and sells medicines for inflammatory and cardiovascular conditions, led by ARCALYST for recurrent pericarditis and cardiac sarcoidosis, with additional antibody based drugs KPL-387 and KPL-116 moving through clinical and pre clinical stages.

Operations: Kiniksa Pharmaceuticals International generates US$840.85m in revenue from developing and delivering therapeutic medicines.

Market Cap: US$6.10b

Kiniksa Pharmaceuticals International may appeal to investors seeking exposure to specialty medicines supported by current cash generation and a growing drug pipeline. ARCALYST is reported as profitable, with rising net income and high payer coverage, and Q2 2026 results cited strong product momentum and higher full year revenue guidance. At the same time, analysts are modeling ambitious revenue and earnings forecasts, and the stock trades on a high P/E relative to many biotech peers, which can leave less room for disappointment if ARCALYST uptake slows or pipeline assets such as KPL-387 and KPL-116 do not meet expectations. That combination of strong fundamentals, concentration risk and an elevated valuation is a key focus for investors evaluating the opportunity.

Kiniksa Pharmaceuticals International appears to be a pure ARCALYST momentum story, yet the current P/E and pipeline profile present a more complicated picture. See how the analyst forecasts for Kiniksa Pharmaceuticals International fits with that risk reward twist investors often overlook.

Sandisk (SNDK)

Overview: Sandisk develops, manufactures and sells NAND flash based storage products, including solid state drives, embedded storage for phones, PCs and connected devices, as well as removable cards and USB drives for customers ranging from hyperscale datacenters to consumer electronics retailers worldwide.

Operations: Sandisk generates about US$13.18b in revenue from developing, manufacturing, marketing and selling data storage devices and solutions.

Market Cap: US$162.25b

Sandisk is positioned in AI and cloud data infrastructure, supplying NAND based storage into datacenters and edge devices where workloads are becoming heavier and capacity needs are increasing. The company has zero debt, multiyear supply agreements with large hyperscalers and a roadmap that includes BiCS10 3D NAND and higher density products. The stock has a relatively rich valuation, has shown sharp share price swings and faces margin risk if NAND supply increases, AI demand slows or hyperscale customers push harder on pricing. For investors, the interest lies in how the company’s growth strategy compares with the concentration, governance and pricing risks that are beginning to appear.

Sandisk’s AI storage story, zero debt and rich valuation suggest something big is building that many investors are only half seeing. Get the full context with the analysis report for Sandisk

The three stocks in this article are only a starting point, and the full Healthy high growth potential screener has identified 258 more companies with similarly compelling narratives through the Healthy high growth potential screener. Use Simply Wall St to identify and analyze the specific catalysts and earnings stories that matter to you, so you can focus on the higher conviction opportunities that best fit your outlook.

Take Control of Your Investment Journey

If Genius Sports or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond Today

Some of the most interesting stock moves can start quietly while attention is focused elsewhere. Explore these fresh stock ideas before they become widely followed and potential entry points change.

• Look for steady cash generators with room to move using a curated 49 high quality undervalued stocks that filters for high quality businesses before their momentum is widely recognized.
• Explore structural themes in automation by scanning the hand picked 34 robotics and automation stocks that highlights companies building the hardware and software behind future factories and warehouses.
• Research opportunities connected to power infrastructure through a focused 34 power grid technology and infrastructure stocks that surfaces potential beneficiaries of grid upgrades while the story is still developing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.